446 related articles for article (PubMed ID: 31332700)
1. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
Marashizadeh A; Sanati HR; Sadeghipour P; Peighambari MM; Moosavi J; Shafe O; Firouzi A; Zahedmehr A; Maadani M; Shakerian F; Kiani R; Mohebbi B; Alemzadeh-Ansari MJ; Tahvili R; Naghavi B
Int Urol Nephrol; 2019 Oct; 51(10):1815-1822. PubMed ID: 31332700
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Lima FV; Singh S; Parikh PB; Gruberg L
Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
4. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate-Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Visconti G; Airoldi F; Signoriello G; Focaccio A
JACC Cardiovasc Interv; 2020 Sep; 13(17):2065-2074. PubMed ID: 32912462
[TBL] [Abstract][Full Text] [Related]
6. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
8. Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.
Liu Y; Li H; Chen S; Chen J; Tan N; Zhou Y; Liu Y; Ye P; Ran P; Duan C; Chen P
J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27233298
[TBL] [Abstract][Full Text] [Related]
9. Elevated left ventricular end diastolic pressure is associated with increased risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
Liu C; Caughey MC; Smith SC; Dai X
Int J Cardiol; 2020 May; 306():196-202. PubMed ID: 32033785
[TBL] [Abstract][Full Text] [Related]
10. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
[TBL] [Abstract][Full Text] [Related]
12. Avoiding the emergence of contrast-induced acute kidney injury in acute coronary syndrome: routine hydration treatment.
Arslan S; Yildiz A; Dalgic Y; Batit S; Kilicarslan O; Ser OS; Dalgic SN; Kocas C; Abaci O
Coron Artery Dis; 2021 Aug; 32(5):397-402. PubMed ID: 33060531
[TBL] [Abstract][Full Text] [Related]
13. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
14. Tailored Versus Standard Hydration to Prevent Acute Kidney Injury After Percutaneous Coronary Intervention: Network Meta-Analysis.
Moroni F; Baldetti L; Kabali C; Briguori C; Maioli M; Toso A; Brilakis ES; Gurm HS; Bagur R; Azzalini L
J Am Heart Assoc; 2021 Jul; 10(13):e021342. PubMed ID: 34169747
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral hydration in the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention.
Akyuz S; Karaca M; Kemaloglu Oz T; Altay S; Gungor B; Yaylak B; Yazici S; Ozden K; Karakus G; Cam N
Nephron Clin Pract; 2014; 128(1-2):95-100. PubMed ID: 25378376
[TBL] [Abstract][Full Text] [Related]
16. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
18. AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.
Usmiani T; Andreis A; Budano C; Sbarra P; Andriani M; Garrone P; Fanelli AL; Calcagnile C; Bergamasco L; Biancone L; Marra S
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):530-7. PubMed ID: 26702595
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial.
Song F; Sun G; Liu J; Chen JY; He Y; Liu L; Liu Y;
Trials; 2019 May; 20(1):290. PubMed ID: 31133052
[TBL] [Abstract][Full Text] [Related]
20. Safe Hydration to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Renal Insufficiency and Heart Failure Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Bei WJ; Wang K; Li HL; Guo XS; Guo W; Abuduaini T; Chen SQ; Islam SMS; Chen PY; Chen JY; Liu Y; Tan N
Int Heart J; 2019 Mar; 60(2):247-254. PubMed ID: 30799374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
